Journal list Promote Sponsor
verified SJR 0,805 · Q2 • database Scopus / SJR & Web of Science indexed
Heart Failure Clinics
United States · Elsevier Inc.
workspace_premium Q2 — Medicine (miscellaneous) lock Subscription

Heart Failure Clinics

Heart Failure Clinics is a journal indexed in SJR in Medicine (miscellaneous) and Cardiology and Cardiovascular Medicine with an H index of 54. It has an SJR impact factor of 0,805 and it has a best quartile of Q2. It has an SJR impact factor of 0,805.

Heart Failure Clinics focuses its scope in these topics and keywords: heart, failure, myocardial, support, therapy, ejection, peptides, preserved, stsegment, ventricle, ...

ISSN: 1551-7136
Publisher: Elsevier Inc.
Category: Medicine (miscellaneous)
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,805 Q2
H-index 54
Acceptance rate pie_chart
32%
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
NPD Subscription
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,805

H-index

54

Docs (year)

55

Docs 3y

181

Total refs

2411

Cites 3y

432

Citable 3y

157

Cites/Doc 2y

2.32

Ref/Doc

43.84

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Cardiac Transplantation: Any Role Left?

View more

What We May Expect from Biomarkers in Heart Failure

View more

Diagnosis of Heart Failure

View more

Destination Therapy: Does Progress Depend on Left Ventricular Assist Device Development?

View more

Depression in Heart Failure: Biobehavioral Mechanisms

View more

DEFEAT Heart Failure: Clinical Manifestations, Diagnostic Assessment, and Etiology of Geriatric Heart Failure

View more

Conduct of Clinical Trials in Acute Heart Failure: Regional Differences in Heart Failure Clinical Trials

View more

Clinical Trials in Mechanical Circulatory Support

View more

Clinical Trials in Acute Decompensated Heart Failure - Over 50 Years of Research

View more

Circulatory Assist Devices in Heart Failure Patients

View more

Chronobiologic Aspects of Venous Thromboembolism

View more

Chemotherapy-Associated Cardiotoxicity: How Often Does it Really Occur and How Can it Be Prevented?

View more
SHOW MORE ARTICLES

Cardiorenal Syndrome Clinical Trial End Points

View more

A Beloved Daughter at Two and a Half

View more

Cardiac Resynchronization Therapy for Treatment of Heart Failure in the Elderly

View more

Cardiac Devices in Emergency Department Heart Failure Patients

View more

Burning Questions in Heart Failure Management: Why Do Surgeons and Interventional Cardiologists Talk of Regenerative Cell Therapy?

View more

Biomarkers of Myocyte Injury in Heart Failure

View more

Biomarkers for Heart Failure in Asia

View more

Biomarkers as Surrogate End Points in Heart Failure Trials

View more

Behavioral Intervention, Nutrition, and Exercise Trials in Heart Failure

View more

Atrial Fibrillation in Heart Failure in the Older Population

View more

Acute Heart Failure Risk Stratification: Can We Define Low Risk?

View more

A Tribute to Michael E. DeBakey

View more

FAQs